Back to search
FDAFDA · Food and drugs·Recall number D-0411-2024

labetalol HCl 20 mg/4mL Injection, (Concentration=5 mg/mL), 4 mL fill Syringe, Rx Only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0700-28, Bar Code 70004070028

Published April 3, 2024 · Recall initiated: November 9, 2023

Summary

FDA records drug Class II recall D-0411-2024, published April 3, 2024 and initiated November 9, 2023. Recalling firm: SCA Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 2,458, syringes; Lot: Lot #: 1223047334 Exp 12/23/23; 1223048170 Exp 02/01/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals, LLC
Distributor
Nationwide in the USA
Lot
Lot #: 1223047334 Exp 12/23/23; 1223048170 Exp 02/01/24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was labetalol HCl 20 mg/4mL Injection, (Concentration=5 mg/mL), 4 mL fill Syringe, Rx Only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0700-28, Bar Code 70004070028 recalled?

Yes. FDA published recall D-0411-2024 on April 3, 2024. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter